Condition (MeSH)
Hyperlactatemia
ClinicalTrials.gov lists 50 trials for Hyperlactatemia or a narrower condition beneath it. Bursa Sevket Yilmaz Training and Research Hospital has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase (log scale)
50 of the 50 trials are tagged with Hyperlactatemia itself; the rest are tagged with a narrower condition beneath it.
When did Hyperlactatemia trials start? (16)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 9
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 3 |
| 2025 | 3 |
| 2024 | 2 |
| 2023 | 1 |
| 2022 | 6 |
| 2021 | 9 |
| 2020 | 5 |
| 2019 | 2 |
| 2018 | 5 |
| 2017 | 7 |
Showing 10 of 16 earlier years.
No forecast is made for this condition: it averages 3.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 4 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Hyperlactatemia trials in? (7)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 2 |
| Phase 1/2 | 1 |
| Phase 2 | 4 |
| Phase 3 | 1 |
| Phase 4 | 3 |
| Not applicable | 22 |
| Observational | 17 |
How many Hyperlactatemia trials are recruiting? (7)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 2 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Completed | 28 |
| Terminated | 1 |
Showing 5 of 7 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Hyperlactatemia trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Bursa Sevket Yilmaz Training and Research Hospital | 1 |
Interventions as named in the registry (15)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| 1% Metformin | 3 |
| Enteral nutrition | 1 |
| Sodium Lactate Solution | 1 |
| Standard Treatment | 1 |
| Lactated Ringer Solution | 1 |
Showing 5 of 15 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Hyperlactatemia trials report? (4)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Cardiac Arrest | 1 | 1 |
| Malnutrition Status Post Dobhoff feeding tube removal | 1 | 1 |
| Refractory Septic Shock (Death) | 1 | 1 |
| Worsening Gangrene | 1 | 1 |
Which publications cover Hyperlactatemia? (22)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Hyperlactatemia in critically ill patients with acute kidney injury treated with renal replacement therapy in the intensive care unit. | BMC nephrology | 2025 | Yes |
| Unraveling mitochondrial pyruvate dysfunction to mitigate hyperlactatemia and lethality in sepsis. | Cell reports | 2025 | Yes |
| Association between lactic acidosis and multiple organ dysfunction syndrome after cardiopulmonary bypass. | PeerJ | 2024 | Yes |
| Effects of exogenous lactate on lipid, protein, and glucose metabolism-a randomized crossover trial in healthy males. | American journal of physiology. Endocrinology and metabolism | 2024 | Yes |
| Effects of norepinephrine infusion during cardiopulmonary bypass on perioperative changes in lactic acid level (Norcal). | Perfusion | 2023 | Yes |
Showing 5 of 22 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.